| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |